BerberineBerberine
herb
别名: Berberine HCl, Berberine Hydrochloride, Goldenseal Extract, Coptis chinensis
About
Berberine activates AMPK, the master metabolic switch, and upregulates LDL receptors via PCSK9 inhibition — a mechanism distinct from and complementary to statins. A landmark 2004 RCT found berberine at 500 mg BID reduced LDL by 25%, triglycerides by 35%, and total cholesterol by 29% — comparable to moderate-dose statins. A 2024 meta-analysis of 46 RCTs confirmed these findings.
How It Works
Activates AMPK in hepatocytes, adipocytes, and skeletal muscle; upregulates LDL receptor expression by stabilizing LDLR mRNA via PCSK9 inhibition, increasing hepatic LDL clearance by a mechanism distinct from statins; reduces hepatic cholesterol synthesis via HMG-CoA reductase inhibition; improves insulin sensitivity by enhancing GLUT4 translocation; inhibits intestinal cholesterol absorption.
Evidence For Conditions
| 健康状况 | 等级 | 研究数量 | 受试者 | |
|---|---|---|---|---|
| High Cholesterol (Hyperlipidemia) | B | 46 | 5000 | 查看 → |
| Metabolic Syndrome (Cardiovascular Aspects) | B | 20 | 2500 | 查看 → |
| High Blood Pressure (Hypertension) | C | 8 | 600 | 查看 → |
Side Effects
- Diarrhea (most common, usually resolves in 2 weeks)
- Constipation
- Flatulence
- Abdominal pain
- May lower blood sugar (monitor in diabetics)
Drug & Supplement Interactions
- Metformin (additive blood sugar lowering; may increase metformin levels)
- CYP2D6 and CYP3A4 substrates (berberine is a CYP inhibitor)
- Cyclosporine (may increase blood levels)
- Macrolide antibiotics (may prolong QT interval)
- Statins (complementary mechanism; monitor for additive effects)
请务必告知您的医疗保健提供者您正在服用的所有补充剂。
Related Ingredients
FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。